RxSight Inc. (RXST) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for RxSight Inc. (RXST:NASDAQ), powered by AI.

Current Price
$4.68
Sector
Healthcare
What is the RxSight Inc. stock price forecast?

RxSight Inc. is currently trading at $4.68. View real-time AI analysis on Alpha Lenz.

What is RxSight Inc. insider trading activity?

View the latest insider trading data for RxSight Inc. on Alpha Lenz.

What is RxSight Inc.'s P/E ratio?

View RxSight Inc.'s valuation metrics on Alpha Lenz.

RxSight Inc.

NASDAQ · RXST
$4.68-0.11(-2.30%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about RxSight Inc.'s future dividend policy...
Alpha Chat Insight

RxSight Inc.'s ROE is -14.0%. Explore profitability and growth together.

Ask for details

Company Overview

RxSight Inc. is a healthcare company specializing in the development and commercialization of innovative ophthalmic implantable devices. Its primary product line includes light adjustable lenses, which allow patients to adjust and customize their vision post-cataract surgery, enhancing visual outcomes. This ability to fine-tune vision is achieved using proprietary technology that utilizes ultraviolet light to adjust the lens power after surgical implantation and healing. RxSight Inc. plays a significant role in the ophthalmology sector, particularly in refractive cataract surgery, offering an advanced solution that addresses limitations of traditional intraocular lenses. With a focus on improving patient satisfaction and enhancing the precision of vision correction, RxSight Inc. is pivotal in advancing eye care solutions and is a key player in medical innovation within the healthcare market landscape.

CEODr. Ronald M. Kurtz M.D.
SectorHealthcare
IndustryMedical Devices
Employees498

Company Statistics

FY 2025

Profile

N/AMarket Cap
$134.48MRevenue
0.00Shares Out
498Employees

Margins

76.60%Gross
-26.47%EBITDA
-35.84%Operating
-28.91%Pre-Tax
-28.96%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

40.00%Rev 3Yr
55.74%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-12.36%ROA
-13.99%ROE
-12.33%ROIC

Financial Health

$19.95MCash & Cash Equivalents
$16.18MNet Debt
13.11%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

RxSight Inc. (ticker: RXST) is a company listed on NASDAQ in the Healthcare sector (Medical Devices). It has approximately 498 employees.

The current price is $4.68 with a P/E ratio of -x and P/B of -x.

ROE is -13.99% and operating margin is -35.84%. Annual revenue is $134M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
RxSight Inc. (RXST) Stock Forecast 2026 $4.68 — Price, Financials & Analyst Targets | Alpha Lenz